Trial intelligence / Profile preview

Rapid sedation-depth airway assessment for anesthesia induction in patients with potential difficult ventilation

ChiCTR-TRC-11001418Phase 4Completed

Sponsor
West China Hospital of Sichuan University
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of sevoflurane in None, Airway Obstruction (AO) and obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Successful intubation rate after loss of consciousness, Successful awake intubation rate and 1 more. Started Aug 2011; status: completed.

02

Drugs

sevoflurane
03

Conditions

Airway Obstruction (AO)obstructive sleep apnea hypopnea syndrome (OSAHS)

Beyond the preview

Go deeper on ChiCTR-TRC-11001418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call